A case of thyrotoxicosis and reversible systolic cardiac dysfunction

Canadian Journal of Cardiology

Volumn 15, Issue 7, 1999, Pages 811-814

  Goldman, Lorne E ^a   Sahlas, Demetrios J ^b   Sami, Magdi ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cardiomyopathy; Congestive heart failure; Left ventricle; Tachycardia; Thyroid

Indexed keywords

FUROSEMIDE; IODINE; METHYLPREDNISOLONE; PROPANOL; PROPYLTHIOURACIL;

ADULT; ARTICLE; ASYSTOLE; CARDIOMYOPATHY; CASE REPORT; CONGESTIVE HEART FAILURE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; THYROTOXICOSIS;

ARRHYTHMIA, SINUS; CARDIOMYOPATHY, DILATED; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; RADIOGRAPHY, THORACIC; SYSTOLE; TACHYCARDIA, VENTRICULAR; THYROTOXICOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032767676     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992;327:94-8.
2. Summers VK, Surtees SJ. Thyrotoxicosis and heart disease. Acta Med Scand 1961;169:661-71.
3. Wilson BE, Newmark SR. Thyrotoxicosis-induced congestive heart failure in an urban hospital. Am J Med Sci 1994;308:344-8.
4. Umpierrez GE, Challapalli S, Patterson C. Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism. Am J Med Sci 1995;310:99-102.
5. Lee TM, Kuo SH, Lee YT. Case report: reversible systolic heart failure and deep jaundice in hyperthyroidism. Am J Med Sci 1996;312:246-8.
6. von Olshausen K, Bischoff S, Kahaly G, et al. Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 1989;63:930-3.
7. Feldman T, Borow KM, Sarne DH, Neumann A, Lang RM. Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 1986;7:967-74.
8. Cavros NG, Old WD, Castro FD, Estep HL. Case report: reversible mitral regurgitation and congestive heart failure complicating thyrotoxicosis. Am J Med Sci 1996;311:142-4.
9. Channick BJ, Adlin EV, Marks AD, et al. Hyperthyroidism and mitral-valve prolapse. N Engl J Med 1981;305:497-500.
10. Ebisawa K, Ikeda U, Murata M, et al. Irreversible cardiomyopathy due to thyrotoxicosis. Cardiology 1994;84:274-7.
11. ATPase and myosin heavy chain alpha gene expression in cardiac myocytes. Delineation of cis-active DNA elements that confer responsiveness to thyroid hormone but not to retinoic acid. J Biol Chem 1991;266:8638-46.
12. Kajstura J, Zhang X, Liu Y, et al. The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995;92:2306-17.
13. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-15.
14. Cruz FE, Cheriex EC, Smeets JL, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol 1990;16:739-44.
15. Corey WA, Markel ML, Hoit BD, Walsh RA. Regression of a dilated cardiomyopathy after radiofrequency ablation of incessant supraventricular tachycardia. Am Heart J 1993;126:1469-73.